'Broad Daylight Dacoity': SC Questions Overpricing of Essential Cancer Drugs
6 Articles
6 Articles
Cancer Drugs Sold to Retailers at INR 2,700 but MRP INR 27,000: Supreme Court Calls It Daylight Robbery | 📰 LatestLY
The Supreme Court called the 10-fold markup on cancer drugs 'broad day light dacoity,' noting essential medicines sold to retailers at INR 2,700 carry an MRP of INR 27,000. Slamming the silence of regulatory authorities, Justice Sandeep Mehta flagged a clear-cut case of fraud where hospitals buy at low PTR and claim inflated reimbursements under state schemes. 📰 Cancer Drugs Sold to Retailers at INR 2,700 but MRP INR 27,000: Supreme Court Calls It Daylight Robbery.
The Supreme Court's Strict Comment: Are cancer patients being defrauded? The Supreme Court has expressed concern over this serious issue. A case of massive price manipulation of essential cancer treatment medicines has emerged in India. The Supreme Court has condemned this malpractice by pharmaceutical companies and hospitals […]
SC Questions on Cancer Drugs: The Supreme Court has strongly objected to the significant difference between the Price to Retailer (PTR) and Maximum Retail Price (MRP) of essential cancer drugs. The court called it a "broadday robbery and open plunder" of patients and questioned the silence of officials.
The Supreme Court termed the 10-fold overcharging of cancer drugs as "daylight robbery" and said the MRP of essential medicines sold to retailers for Rs 2,700 is Rs 27,000.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
